期刊文献+

Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies 被引量:3

Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies
下载PDF
导出
摘要 Zollinger-Ellison syndrome(ZES)is characterized by gastric acid hypersecretion causing severe recurrent acid-related peptic disease.Excessive secretion of gastrin can now be effectively controlled with powerful proton pump inhibitors,but surgical management to control gastrinoma itself remains controversial.Based on a thorough literature review,we design a surgical algorithm for ZES and list some significant consensus findings and recommendations:(1)For sporadic ZES,surgery should be routinely undertaken as early as possible not only for patients with a precisely localized diagnosis but also for those with negative imaging findings.The surgical approach for sporadic ZES depends on the lesion location(including the duodenum,pancreas,lymph nodes,hepatobiliary tract,stomach,and some extremely rare sites such as the ovaries,heart,omentum,and jejunum).Intraoperative liver exploration and lymphadenectomy should be routinely performed;(2)For multiple endocrine neoplasia type 1-related ZES(MEN1/ZES),surgery should not be performed routinely except for lesions>2 cm.An attempt to perform radical resection(pancreaticoduodenectomy followed by lymphadenectomy)can be made.The ameliorating effect of parathyroid surgery should be considered,and parathyroidectomy should be performed first before any abdominal surgery for ZES;and(3)For hepatic metastatic disease,hepatic resection should be routinely performed.Currently,liver transplantation is still considered an investigational therapeutic approach for ZES.Well-designed prospective studies are desperately needed to further verify and modify the current considerations. Zollinger-Ellison syndrome(ZES) is characterized by gastric acid hypersecretion causing severe recurrent acid-related peptic disease. Excessive secretion of gastrin can now be effectively controlled with powerful proton pump inhibitors,but surgical management to control gastrinoma itself remains controversial.Based on a thorough literature review, we design a surgical algorithm for ZES and list some significant consensus findings and recommendations:(1) For sporadic ZES, surgery should be routinely undertaken as early as possible not only for patients with a precisely localized diagnosis but also for those with negative imaging findings. The surgical approach for sporadic ZES depends on the lesion location(including the duodenum, pancreas, lymph nodes,hepatobiliary tract, stomach, and some extremely rare sites such as the ovaries,heart, omentum, and jejunum). Intraoperative liver exploration and lymphadenectomy should be routinely performed;(2) For multiple endocrine neoplasia type 1-related ZES(MEN1/ZES), surgery should not be performed routinely except for lesions > 2 cm. An attempt to perform radical resection(pancreaticoduodenectomy followed by lymphadenectomy) can be made. The ameliorating effect of parathyroid surgery should be considered, and parathyroidectomy should be performed first before any abdominal surgery for ZES; and(3) For hepatic metastatic disease, hepatic resection should be routinely performed. Currently, liver transplantation is still considered an investigational therapeutic approach for ZES. Well-designed prospective studies are desperately needed to further verify and modify the current considerations.
出处 《World Journal of Gastroenterology》 SCIE CAS 2019年第32期4673-4681,共9页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation,No.81773215 the General Financial Grant from the China Postdoctoral Science Foundation,No.2017M610813
关键词 Zollinger-Ellison syndrome SPORADIC gastrinomas Multiple ENDOCRINE NEOPLASIA type 1 Hepatic METASTATIC disease Surgical treatment Zollinger-Ellison syndrome Sporadic gastrinomas Multiple endocrine neoplasia type 1 Hepatic metastatic disease Surgical treatment
  • 相关文献

参考文献1

二级参考文献54

  • 1Pierre Goudet,Arnaud Murat,Christine Binquet,Christine Cardot-Bauters,Annie Costa,Philippe Ruszniewski,Patricia Niccoli,Fabrice Ménégaux,Georges Chabrier,Fran?oise Borson-Chazot,Antoine Tabarin,Philippe Bouchard,Brigitte Delemer,Alfred Beckers,Claire Bonithon-Kopp.Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients[J]. World Journal of Surgery . 2010 (2)
  • 2Tetsuhide Ito,Hironobu Sasano,Masao Tanaka,R. Yoshiyuki Osamura,Iwao Sasaki,Wataru Kimura,Koji Takano,Takao Obara,Miyuki Ishibashi,Kazuwa Nakao,Ryuichiro Doi,Akira Shimatsu,Toshirou Nishida,Izumi Komoto,Yukio Hirata,Kazuhiko Nakamura,Hisato Igarashi,Robert T. Jensen,Bertram Wiedenmann,Masayuki Imamura.Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan[J]. Journal of Gastroenterology . 2010 (2)
  • 3Günter Kl?ppel,Martin Anlauf,Aurel Perren.Endocrine Precursor Lesions of Gastroenteropancreatic Neuroendocrine Tumors[J]. Endocrine Pathology . 2007 (3)
  • 4Tetsuhide Ito,Masao Tanaka,Hironobu Sasano,Yoshiyuki R. Osamura,Iwao Sasaki,Wataru Kimura,Koji Takano,Takao Obara,Miyuki Ishibashi,Kazuwa Nakao,Ryuichiro Doi,Akira Shimatsu,Toshirou Nishida,Izumi Komoto,Yukio Hirata,Masayuki Imamura,Ken Kawabe,Kazuhiko Nakamura.Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors[J]. Journal of Gastroenterology . 2007 (6)
  • 5Guida Maria Portela-Gomes,Mats Stridsberg,Lars Grimelius,Otto Rorstad,Eva Tiensuu Janson.Differential Expression of the Five Somatostatin Receptor Subtypes in Human Benign and Malignant Insulinomas – Predominance of Receptor Subtype 4[J]. Endocrine Pathology . 2007 (2)
  • 6Masayuki Imamura MD,Izumi Komoto MD,Shuichi Ota MD.Changing Treatment Strategy for Gastrinoma in Patients with Zollinger-Ellison Syndrome[J]. World Journal of Surgery . 2006 (1)
  • 7Masayuki Imamura M.D.,Izumi Komoto M.D.,Ryuichiro Doi M.D.,Hisashi Onodera M.D.,Hiroyuki Kobayashi M.D.,Yasuhiro Kawai M.D..New Pancreas-preserving Total Duodenectomy Technique[J]. World Journal of Surgery . 2005 (2)
  • 8Masayuki Kato,Masayuki Imamura,Ryo Hosotani,Yutaka Shimada,Ryuichiro Doi,Atsushi Itami,Izumi Komoto,Tadako Kosaka,Junji Konishi.Curative Resection of Microgastrinomas Based on the Intraoperative Secretin Test[J]. World Journal of Surgery . 2000 (11)
  • 9Masayuki Imamura,Yutaka Shimada,Masayuki Kato,Ryuichirou Doi,Noriyuki Okada,Mituaki Hashimoto.Usefulness of selective arterial calcium injection test and secretin test in patients with insulinoma[J]. Journal of Hepato - Biliary - Pancreatic Surgery . 1994 (5)
  • 10Diarmuid S. O’Riordain M.B.,Timothy O’Brien M.B.,Jon A. Heerden M.B.,F. J. Service M.D., Ph.D.,Clive S. Grant M.D..Surgical management of insulinoma associated with multiple endocrine neoplasia type I[J]. World Journal of Surgery . 1994 (4)

共引文献9

同被引文献30

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部